CVC in talks to buy Recordati pharma business: Financial Times

CVC is in advanced talks to buy a controlling stake in the pharmaceutical business of Italy’s billionaire Recordati family, the Financial Times reported. A deal, valued at 3 billion euros ($3.5 billion), could be reached before the end of the month, the story said.